Bone or cartilage mass differential diagnosis: Difference between revisions
Ahmed Younes (talk | contribs) |
Mahshid |
||
Line 127: | Line 127: | ||
==References== | ==References== | ||
{{reflist|1}} | {{reflist|1}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Rheumatology]] | |||
[[Category:Orthopedics]] |
Latest revision as of 02:31, 6 November 2017
Bone or Cartilage Mass Microchapters |
Diagnosis |
---|
Case Studies |
Bone or cartilage mass differential diagnosis On the Web |
American Roentgen Ray Society Images of Bone or cartilage mass differential diagnosis |
Risk calculators and risk factors for Bone or cartilage mass differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Bone and cartilage tumors may be differentiated according to clinical features, laboratory findings, imaging features, histological features, and genetic studies, from other diseases that cause limited range of motion, limb deformity, bone pain, and local swelling.[1][2] Common differential diagnosis includes: osteoma, osteosarcoma, chondroma, chondrosarcoma, Ewing sarcoma, giant cell tumor, and metastases.
Common Differential Diagnosis
- The table below summarizes common differential diagnosis of bone and cartilage tumors, that differentiate bone tumors according to type of tumor, age, location, histological features, imaging features, tissue of origin.
Type of tumor | Age | Location | Histological features | Imaging features | Origin | Bone/Cartilage |
---|---|---|---|---|---|---|
Osteoma | 40-50 years | Skull bones | Matured lamellar bone | Sclerotic | Benign | Bone |
Osteoid osteoma | 10-20 years | Short and long bone diaphysis | Osteiod outlined by osteoblasts, incorporated in a fibrous stroma | Sclerotic | Benign | Bone |
Osteosarcoma | 11-40 years | Long bones metaphysis | Osteoid and bone formed of malignant osteoblasts and fibroblasts | Sclerotic | Malignant | Bone |
Chondroma | 30-60 years | Small tubular bones of the hands and feet | Maturated hyaline cartilage (enchondroma/ecchondroma), preserving lobulation | Well-defined | Malignant | Cartilage |
Chondrosarcoma | 30-60 years | Long bones metaphysis, axial skeleton | Immature cartilage, no preserving lobulation, cells arranged in groups of two or four, with atypia and mitosis | Well-defined | Malignant | Cartilage |
Ewing sarcoma | 5-25 years | Long bones diaphysis | Small, round, undifferentiated cells, no stroma, a lot of capillary arrangement. | Ill-defined | Malignant | Bone |
Giant cell tumor | 20-40 years | Knee | Multinucleated giant cells, fusiform cells, mononuclear cells. | Well-defined | Malignant | Bone |
Metastases | 50-90 years | No site predilection | Frequently adenocarcinomas. Metastases can be blastic or lytic depending on the tumor origin | Sclerotic | Malignant | Bone |
Differential Diagnosis
- The table below summarizes the findings that differentiate bone tumors according to clinical features, laboratory findings, imaging features, histological features, and genetic studies.
Disease Name | History & Symptoms | Physical Exam | Lab Findings | Imaging Findings | Histologic Findings | Genetic Studies |
---|---|---|---|---|---|---|
Adamantinoma |
|
|
|
|
|
|
Ameloblastoma |
|
|
|
|
|
|
Aneurysmal bone cyst |
|
|
|
|
|
|
Unicameral bone cyst |
|
|
|
|
|
|
Brown tumor |
|
|
|
|
|
|
Chondroblastoma |
|
|
|
|
|
|
Chondromyxoid fibroma |
|
|
|
|
|
|
Chondrosarcoma |
|
|
|
|
|
|
Desmoplastic fibroma |
|
|
|
|
|
|
Enchondroma |
|
|
|
|
|
|
Ewing sarcoma |
|
|
|
|
|
|
Fibrosarcoma |
|
|
|
|
|
|
Fibrous dysplasia |
|
|
|
|
|
|
Giant cell tumor |
|
|
|
|
|
|
Ossifying fibroma |
|
|
|
|
|
|
Osteoblastoma |
|
|
|
|
|
|
Osteochondroma |
|
|
|
|
|
|
Osteoid osteoma |
|
|
|
|
|
|
Osteosarcoma |
|
|
|
|
|
|
Plasmacytoma |
|
|
|
|
|
|
Eosinophilic Granuloma |
|
|
|
|
|
|
Brodie abscess |
|
|
|
|
|
|
Osteoma |
|
|
|
|
|
|
Intraosseous lipoma |
|
|
|
|
|
|
Enostosis |
|
|
|
|
|
|
Chordoma |
|
|
|
|
|
|
Bone metastasis |
|
|
|
|
|
|
Intraosseous ganglion |
|
|
|
|
|
|
Bone mass must be differentiated from other diseases that cause bone pain, edema, and erythema.
Disease | Findings |
---|---|
Soft tissue infection (Commonly cellulitis) |
History of skin warmness, swelling and erythema. Bone probing is the definite way to differentiate them.[3][4] |
Osteonecrosis (Avascular necrosis of bone) |
Previous history of trauma, radiation, use of steroids or biphosphonates are suggestive to differentiate osteonecrosis from ostemyelitis.[5][6] MRI is diagnostic.[7][8] |
Charcot joint | Patients with Charcot joint commonly develop skin ulcerations that can in turn lead to secondary osteomyelitis. Contrast-enhanced MRI may be diagnostically useful if it shows a sinus tract, replacement of soft tissue fat, a fluid collection, or extensive marrow abnormalities. Bone biopsy is the definitive diagnostic modality.[9] |
Bone tumors | May present with local pain and radiographic changes consistent with osteomyelitis. Tumors most likely to mimic osteomyelitis are osteoid osteomas and chondroblastomas that produce small, round, radiolucent lesions on radiographs.[10] |
Gout | Gout presents with joint pain and swelling. Joint aspiration and crystals in synovial fluid is diagnostic for gout.[11] |
SAPHO syndrome (Synovitis, acne, pustulosis, hyperostosis, and osteitis) |
SAPHO syndrome consists of a wide spectrum of neutrophilic dermatosis associated with aseptic osteoarticular lesions. It can mimic osteomyelitis in patients who lack the characteristic findings of pustulosis and synovitis. The diagnosis is established via clinical manifestations; bone culture is sterile in the setting of osteitis. |
Sarcoidosis | It involves most frequently the pulmonary parenchyma and mediastinal lymph nodes, but any organ system can be affected. Bone involvement is often bilateral and bones commonly affected include the middle and distal phalanges (producing “sausage finger”), wrist, skull, vertebral column, and long bones. |
Langerhans' cell histiocytosis | The disease usually manifests in the skeleton and solitary bone lesions are encountered twice as often as multiple bone lesions. The tumours can develop in any bone, but most commonly originate in the skull and jaw, followed by vertebral bodies, ribs, pelvis, and long bones.[12] |
References
- ↑ Alina Maria Sisu. On the Bone Tumours: Overview, Classification, Incidence, Histopathological Issues, Behavior and Review Using Literature Data. http://www.intechopen.com/books/histopathology-reviews-and-recent-advances/on-the-bone-tumours-overview-classification-incidence-histopathological-issues-behavior-and-review Accessed on February 2, 2016
- ↑ Bone tumors. https://en.wikipedia.org/wiki/Bone_tumor Accessed on February 2, 2016
- ↑ Bisno AL, Stevens DL (1996). "Streptococcal infections of skin and soft tissues". N. Engl. J. Med. 334 (4): 240–5. doi:10.1056/NEJM199601253340407. PMID 8532002.
- ↑ Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC (2014). "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America". Clin. Infect. Dis. 59 (2): 147–59. doi:10.1093/cid/ciu296. PMID 24947530.
- ↑ Shigemura T, Nakamura J, Kishida S, Harada Y, Ohtori S, Kamikawa K, Ochiai N, Takahashi K (2011). "Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study". Rheumatology (Oxford). 50 (11): 2023–8. doi:10.1093/rheumatology/ker277. PMID 21865285.
- ↑ Slobogean GP, Sprague SA, Scott T, Bhandari M (2015). "Complications following young femoral neck fractures". Injury. 46 (3): 484–91. doi:10.1016/j.injury.2014.10.010. PMID 25480307.
- ↑ Amanatullah DF, Strauss EJ, Di Cesare PE (2011). "Current management options for osteonecrosis of the femoral head: part 1, diagnosis and nonoperative management". Am J. Orthop. 40 (9): E186–92. PMID 22022684.
- ↑ Etienne G, Mont MA, Ragland PS (2004). "The diagnosis and treatment of nontraumatic osteonecrosis of the femoral head". Instr Course Lect. 53: 67–85. PMID 15116601.
- ↑ Ahmadi ME, Morrison WB, Carrino JA, Schweitzer ME, Raikin SM, Ledermann HP (2006). "Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics". Radiology. 238 (2): 622–31. doi:10.1148/radiol.2382041393. PMID 16436821.
- ↑ Lovell, Wood (2014). Lovell and Winter's pediatric orthopaedics. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. ISBN 978-1605478142.
- ↑ Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, Stienstra R, van de Veerdonk FL, Stalenhoef AF, Giamarellos-Bourboulis EJ, Kanneganti TD, van der Meer JW (2010). "Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis". Arthritis Rheum. 62 (11): 3237–48. doi:10.1002/art.27667. PMC 2970687. PMID 20662061.
- ↑ Picarsic J, Jaffe R (2015). "Nosology and Pathology of Langerhans Cell Histiocytosis". Hematol. Oncol. Clin. North Am. 29 (5): 799–823. doi:10.1016/j.hoc.2015.06.001. PMID 26461144.